{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0069-8140",
      "generic_name": "CRIZOTINIB",
      "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
      "brand_name": "Xalkori",
      "active_ingredients": [
        {
          "name": "CRIZOTINIB",
          "strength": "250 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0069-8140-20",
          "description": "60 CAPSULE in 1 BOTTLE (0069-8140-20)",
          "marketing_start_date": "20110826",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Pfizer Laboratories Div Pfizer Inc"
        ],
        "rxcui": [
          "1148498",
          "1148502",
          "1148504",
          "1148506",
          "2670166",
          "2670170",
          "2670172",
          "2670174",
          "2670176",
          "2670178"
        ],
        "spl_set_id": [
          "2a51b0de-47d6-455e-a94c-d2c737b04ff7"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0300698140201",
          "0300690507606",
          "0300690251608",
          "0300691500606",
          "0300698141208"
        ],
        "nui": [
          "N0000175605",
          "N0000190114",
          "N0000020000",
          "N0000182139",
          "N0000185503",
          "N0000191265",
          "N0000187061"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Cytochrome P450 3A Inhibitors [MoA]",
          "Receptor Tyrosine Kinase Inhibitors [MoA]",
          "Cytochrome P450 2B6 Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Organic Cation Transporter 1 Inhibitors [MoA]",
          "Organic Cation Transporter 2 Inhibitors [MoA]"
        ],
        "unii": [
          "53AH36668S"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "CAPSULE",
      "spl_id": "f5e01d3a-43fc-4fa6-b5dd-a07330b49328",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20110826",
      "product_id": "0069-8140_f5e01d3a-43fc-4fa6-b5dd-a07330b49328",
      "application_number": "NDA202570",
      "brand_name_base": "Xalkori",
      "pharm_class": [
        "Cytochrome P450 2B6 Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Kinase Inhibitor [EPC]",
        "Organic Cation Transporter 1 Inhibitors [MoA]",
        "Organic Cation Transporter 2 Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]",
        "Receptor Tyrosine Kinase Inhibitors [MoA]"
      ]
    }
  ]
}